Zomedica (NYSEMKT:ZOM) just reported results for the fourth quarter of 2023. Zomedica reported earnings per share of -2.3 cents. The company reported revenue of $7.34 million. This was 4.81% ...

(NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company offering point-of-care diagnostic and therapeutic ... ANN ARBOR, MI / ACCESS Newswire / February 26 ...

Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health Zomedica Corp (AMEX: ZOM) launches 2 new canine assays for its TRUFORMA platform. NT-proBNP test detects ...